GE HealthCare Technologies Inc. $GEHC Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 83.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,210 shares of the company’s stock after selling 11,553 shares during the period. TD Private Client Wealth LLC’s holdings in GE HealthCare Technologies were worth $164,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $25,000. Bogart Wealth LLC grew its stake in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares during the period. Stonebridge Financial Group LLC grew its stake in GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after acquiring an additional 222 shares during the period. Olde Wealth Management LLC purchased a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $35,000. Finally, Zions Bancorporation National Association UT purchased a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $42,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $72.46 on Monday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The firm has a market capitalization of $33.08 billion, a P/E ratio of 14.85, a P/E/G ratio of 2.77 and a beta of 1.13. The company’s fifty day moving average price is $74.35 and its two-hundred day moving average price is $72.71.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Analyst Ratings Changes

Several analysts have recently issued reports on GEHC shares. Morgan Stanley set a $74.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Zacks Research raised shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 28th. Finally, BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.